Key facts
- This page summarizes Robert Curtis McRae's Form 4 filing for PALISADE BIO, INC. (PALI).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 05 Apr 2023, 18:52.
Robert Curtis McRae - 03 Apr 2023 Form 4 Insider Report for PALISADE BIO, INC. (PALI)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- PALI
- Reported as of
- 03 Apr 2023
- Net transaction value
- -$540
- SEC form
- 4
- Accepted by SEC
- 05 Apr 2023, 18:52:42 UTC
- Prior SEC filing
- 15 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Robert McRae
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Robert Curtis McRae filed Form 4 for PALISADE BIO, INC. (PALI) on 05 Apr 2023.
Change
- Previous filing in this sequence was filed on 15 Feb 2023.
- Current net transaction value: -$540.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PALI
transaction
Common Stock, par value $0.01
Options Exercise
- Transaction value
- $0
- Shares
- +655
- Change %
- +273%
- Price
- $0.000000
- Shares after
- 895
- Date
- 03 Apr 2023
- Ownership
- Direct
- Footnotes
- F1
PALI
transaction
Common Stock, par value $0.01
Tax liability
- Transaction value
- $540
- Shares
- -270
- Change %
- -30%
- Price
- $2.00
- Shares after
- 625
- Date
- 03 Apr 2023
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PALI
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -655
- Change %
- -25%
- Price
- Shares after
- 1,963
- Date
- 03 Apr 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 655
- Exercise price
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.
Footnote F2
Represents shares withheld by Issuer to satisfy tax withholding requirements on vesting of restricted stock units.
Footnote F3
This restricted stock unit was granted on January 3, 2023, and 655 restricted stock units subject to the award vested on April 3, 2023, and approximately 654 restricted stock units are scheduled to vest on each of July 3, 2023, October 3, 2023, and January 3, 2023, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.